Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan-Reference-Cited by-同舟云学术

Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan

Published:2018-10 Issue: Volume:136 Page:133-139
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Salvador-Martín Sara,García-González Xandra,García María I.,Blanco Carolina,García-Alfonso Pilar,Robles Luis,Grávalos Cristina,Pachón Vanessa,Longo Federico,Martínez Virginia,Sanjurjo-Sáez María,López-Fernández Luis A.

Funder

Ministry of Economy and Competitiveness ISCIII-FIS

Consejería de Educación y Deporte de la Comunidad de Madrid

Gregorio Marañón Health Research Institute (XG-G)

ERDF Funds (FEDER) from the European Commission, “A way of making Europe”

Publisher

Elsevier BV

Subject

Pharmacology

Reference45 articles.

1. The long story of camptothecin: from traditional medicine to drugs;Martino;Bioorg. Med. Chem. Lett.,2017

2. Concomitant polypharmacy is associated with irinotecan-related adverse drug reactions in patients with cancer;Sasaki;Int. J. Clin. Oncol.,2013

3. Toxic effects and their management: daily clinical challenges in the treatment of colorectal cancer;Eng;Nat. Rev. Clin. Oncol.,2009

4. Association of UGT1A1*28 polymorphisms with irinotecan-induced toxicities in colorectal cancer: a meta-analysis in Caucasians;Liu;Pharmacogenomics J.,2014

5. Collective work by Groupe de Pharmacologie Clinique Oncologique (GPCO-Unicancer), French Réseau National de Pharmacogénétique Hospitalière (RNPGx), UGT1A1 genotype and irinotecan therapy: general review and implementation in routine practice;Etienne-Grimaldi;Fundam. Clin. Pharmacol.,2015

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An accurate haplotyping method using multiplex pyrosequencing with AS-PCR to detect ABCB1 haplotypes associated with rivaroxaban-derived hemorrhagic events;Talanta;2025-01

2. Mechanisms and emerging strategies for irinotecan-induced diarrhea;European Journal of Pharmacology;2024-07

3. A systematic review and meta‐analysis of the impacts of germline pharmacogenomics on severe toxicity and symptom burden in adult patients with cancer;Clinical and Translational Science;2024-05

4. Role of MRPs transporters in pharmacokinetics and intestinal toxicity of irinotecan;Food and Chemical Toxicology;2023-12

5. Irinotecan-Induced Toxicity: A Pharmacogenetic Study Beyond UGT1A1;Clinical Pharmacokinetics;2023-09-16